Book Value Per Share: The amount of equity available to shareholders expressed on a per common share basis. Calculated as: Total Shareholders Equity / Common Shares Outstanding
10x Genomics (TXG) had Book Value Per Share of $6.21 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$172.91M |
|
$34.54M |
|
$47.82M |
|
$125.08M |
|
$142.78M |
|
$30.13M |
|
$6.87M |
|
$37.00M |
|
$37.00M |
|
$34.54M |
|
$34.54M |
|
$34.54M |
|
$34.54M |
|
$30.13M |
|
$39.78M |
|
123.76M |
|
124.51M |
|
$0.28 |
|
$0.28 |
|
| Balance Sheet Financials | |
$655.66M |
|
$239.71M |
|
$324.31M |
|
$979.97M |
|
$112.22M |
|
-- |
|
$94.47M |
|
$206.69M |
|
$773.28M |
|
$754.05M |
|
$773.28M |
|
124.44M |
|
| Cash Flow Statement Financials | |
$52.06M |
|
$-2.83M |
|
$3.94M |
|
$344.07M |
|
$397.71M |
|
$53.65M |
|
$58.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.84 |
|
-- |
|
-- |
|
-- |
|
-- |
|
72.34% |
|
17.42% |
|
17.42% |
|
-- |
|
21.40% |
|
19.97% |
|
$48.59M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
0.69 |
|
1.45 |
|
61.98 |
|
4.47% |
|
4.58% |
|
3.52% |
|
4.47% |
|
|
Book Value Per Share |
$6.21 |
$0.39 |
|
$0.42 |
|